Siemens Healthineers and HeartFlow Collaborate to Provide Solution that Has Potential to Lower Cardiac Care Costs

Siemens HealthineersSiemens Healthineers and HeartFlow, Inc. have entered into a global collaboration agreement to provide a comprehensive, noninvasive solution to support the diagnosis and management of patients with suspected coronary artery disease (CAD). HeartFlow is a pioneer in personalized medical technology to aid in the diagnosis and treatment of CAD. Siemens Healthineers aims to enable healthcare providers to meet current challenges and excel in their respective environments. To execute this strategy in the field of cardiology, Siemens Healthineers is collaborating with HeartFlow and contributing its strength in computed tomography (CT).

The collaboration's joint solution pairs CT scanners from Siemens Healthineers, which provide excellent image quality, with the HeartFlow FFRct Analysis, the first noninvasive technology to provide insight into both the extent of coronary artery disease and the impact that disease has on blood flow to the heart.

Using CT images, the HeartFlow FFRct Analysis creates a personalized 3D model of each patient's arteries; computer algorithms then simulate blood flow and assess the impact of arterial blockages. The combined clinical pathway of coronary CT angiography (cCTA) and the HeartFlow FFRct Analysis offers actionable information that helps physicians determine each patient's optimal course of treatment. Published clinical data(1) demonstrate that use of the HeartFlow FFRct Analysis may prevent unnecessary invasive angiograms.

Although the United States is the initial commercial focus of this collaboration agreement, the two companies plan to expand their efforts to additional geographic markets in the future.

"It is a fact that the treatment planning for coronary artery disease patients can be improved via quantitative data out of FFR measurements. With our exciting partnership between Siemens Healthineers and HeartFlow, Inc., we create an integrated solution that combines the exceptional cCTA images acquired by our high performance scanners with the only commercial product available that can derive FFR analysis noninvasively from CT data," said André Hartung, Head of Computed Tomography at Siemens Healthineers.

"HeartFlow is pleased to collaborate with Siemens Healthineers, with its outstanding technology, tremendous expertise, and global reach," said John H. Stevens, MD, chairman and CEO of HeartFlow. "Like HeartFlow, Siemens Healthineers is deeply committed to helping clinicians improve the patient experience and clinical outcomes while also helping them to reduce the total cost of healthcare. By working together, we can ensure this technology gets to every patient who can benefit from it."

1. Douglas, P.S., DeBruyne, B., Pontone, G., Patel, MR, et al. (2016). 1-Year Outcomes of FFRCT-Guided Care in Patients with Suspected Coronary Disease: The PLATFORM Study. J Am Coll Cardiol, 68(5), 435-45.

About Siemens Healthineers
Siemens Healthineers is the separately managed healthcare business of Siemens AG enabling healthcare providers worldwide to meet their current challenges and to excel in their respective environments. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. To help customers succeed in today's dynamic healthcare marketplace, Siemens Healthineers is championing new business models that maximize opportunity and minimize risk for healthcare providers. In fiscal 2016, which ended on September 30, 2016, Siemens Healthineers generated revenue of €13.5 billion and net income of over €2.3 billion and has about 46,000 employees worldwide.

About HeartFlow, Inc.
HeartFlow, Inc. is a personalized medical technology company seeking to transform the way cardiovascular disease is diagnosed and treated. The company's HeartFlow FFRct Analysis is the first available non-invasive solution that enables a physician to more accurately evaluate whether a patient has significant coronary artery disease (CAD) based on both anatomy and physiology. The solution, which leverages deep learning to create a personalized 3D model of the patient's arteries, is well positioned to become an integral part of the standard of care for patients who are at risk for CAD because of its potential to improve clinical outcomes, improve the patient experience and reduce the cost of care. The HeartFlow FFRct Analysis is available in the United States, Canada, Europe and Japan.

Most Popular Now

Augmented Reality Visor to Dramatically …

Employing new photonics technology, European scientists are developing a new Augmented Reality surgical visor in a bid to improve accuracy of interventions, showing anaesthetic and medical data while superimposing a...

Read more

Interactive Health Apps May Inspire Heal…

Just like real doctors and nurses, online health tools with good - but controlled - communication skills can promote healthier lifestyles, according to researchers. However, if their tone is conversational...

Read more

Call for Papers: EHB 2017 - IEEE Interna…

22 - 24 June 2017, Sinaia, Romania. The 6-th edition of the International Conference on e-Health and Bioengineering, EHB 2017, will take place in the city of Sinaia, Romania. This year...

Read more

UK and Italian Health Tech Firms to Help…

Data sharing ambitions set out in newly published sustainability and transformation plans (STPs) have been given a boost by a new strategic partnership between data management specialist Stalis and Italy's...

Read more

From Health Apps to Nursing Robots - A G…

25 - 27 April 2017, Berlin, Germany. Around the world the subject of e-Health is steadily gaining in importance, whether it involves electronic patient files, online video consultations or any of...

Read more

Philips Teams Up with German Startup One…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a partnership agreement with German digital health company Onelife Health to jointly develop innovative connected health...

Read more

EU eHealth Competition 2017

The eHealth Competition is an initiative that rewards the best eHealth / mHealth solutions produced by European SMEs (Small and Medium Enterprises). Its objective is to support business success of...

Read more

Philips and LabPON Plan to Create World…

Royal Philips (NYSE: PHG, AEX: PHIA) and LabPON, the first clinical laboratory to transition to 100% histopathology digital diagnosis, have announced its plans to create a digital database of massive...

Read more

Virtual Reality Cognitive Training Game …

Greek researchers demonstrated the potential of a self-administered virtual supermarket cognitive training game for remotely detecting mild cognitive impairment (MCI), without the need for an examiner, among a sample of...

Read more

Technology Boost for Health and Social C…

Health and social care organisations aiming to be fully compliant with the government’s Personalised Health and Care 2020 plan, can now access electronic health record (EHR) and healthcare integration technologies...

Read more

Agfa HealthCare's Health Management Pla…

Agfa HealthCare announces today that its health management platform, including the XERO universal image viewer, has been selected to support the joint Radiotherapy Treatment Project of the Saolta University Health...

Read more

Philips Introduces Advanced Radiology So…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has unveiled new advanced radiology solutions at the 2017 European Congress of Radiology (ECR). In response to today's...

Read more
(HEALTH IT) SPACE - Take a look at who has just Joined